In-vivo studies on the pharmacokinetics of berberine on middle cerebral artery occlusion rat and sham-operated rat

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 16, 2011, Pages 1824-1831

  Pan, Linmei ^a   Qiu, Bihan ^a   Li, Huan ^a   Zeng, Mingfei ^a   Zhu, Huaxu ^a   Zhang, Qichun ^a   Guo, Liwei ^a   Qian, Zhilei ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Berberine; Compatibility; Huang Lian Jie Du Tang; Middle cerebral artery occlusion (MCAO); Pharmacokinetics

Indexed keywords

BERBERINE; CHINESE DRUG; HUANG LIAN JIE DU TANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BARK; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; FRUIT; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PLANT ROOT; RAT; RHIZOME;

EID: 80655143791     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bederson JB, Pitts LH, Tsuji MT, Nishimura MC, Davis RL, Bartkowski (1986). Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke, 17: 472-476.
2. Chen CM, Chang HC (1995). Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J. Chrom., B, 665: 117-123.
3. Chen ZY, Zheng QS, Sun RY (2002). Functions of the DAS software for pharmacological calculation. Chin. J. Clin. Pharmacol. Theory, 7: 562-564.
4. Cho EJ, Yokozawa T, Rhee SH, Park KY (2004). The role of Coptidis Rhizoma extract in a renal ischemia-reperfusion model. Phytomedicine 11: 576-584.
5. Deng YT, Liao QF, Li SH, Bi KS, Pan BY, Xie ZY (2008). Simultaneous determination of berberine, palmatine and jatrorrhizine by liquid chromatography-tandem mass spectrometry in rat plasma and its application in a pharmacokinetics study after oral administration of coptis-evodia herb couple. J. Chromatogr., B 863: 195-205.
6. Fujiwara M, Iwasaki K (1993). Toki-shakuyaku-San and Oren-Gedoku-To improve the disruption of spatial cognition induced by cerebral ischeamia and central cholinergic dysfunction in rats. Phytother. Res., 7: S60-S62.
7. Gupta PK, Hubbard M, Gurley B, Hendrickson HP (2009). Validation of a liquid chromatography-tandem mass spectrometric assay for the quantitative determination of hydrastine and berberine in human serum. J. Pharm. Biomed. Anal., 49: 1021-1026.
8. Hua WY, Ding L, Chen Y, Gong B, He JC, Xu GL (2007). Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. J. Pharm. Biomed. Anal., 44:931-937.
9. Hwang YS, Shin CY, Huh Y, Jong HR (2002). Hwangryun-Hae-Dok-tang (Huang-lian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci., 71:2105-2117.
10. Itoh T (2001). Application of Oren-gedoku-to to many illnesses in Japanese oriental medicine. Kampo Newest Therapy, 10: 243-246.
11. Kabuto, H, Asanuma M., Nishibayashi S., Iida M, Ogawa N (1997). Chronic administration of Oren-gedoku-to (TJ15) inhibits ischemia-induced changes in brain indoleamine metabolism and muscarinic receptor binding in the Mongolian gerbil. Neurochem. Res., 22: 33-36.
12. Li BX, Yang BF, Hao XM (2000). Study on the pharmacokinetics of berberine in single dosage and coadministration with oryzanol in rabbits and healthy volunteers. Chin. Pharm. J., 35: 33-35.
13. Longa EZ, Weinstein PR, Carlsion S, Cummins R (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20: 84-91.
14. Lu T, Liang Y, Song J, Xie L, Wang GJ, Liu XD (2006). Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetics application of the method. J. Pharm. Biomed. Anal., 40: 1218-1224.
15. Markgraf CG, kraydieh S, Prado R, Watson BD, Dietrich WD, Ginsberg MD (1993). Comparative histopathologic, consequences of photohrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistary rats. Stroke, 24: 286-292.
16. Nagasawa H, Kogure K (1989). Correlation between cererbral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke, 20:1037-1043.
17. Tang J, Feng YB, Tsao SW, Wang N, Curtain R, Wang YW (2009). Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J. Ethnopharmacol., 126: 5-17.
18. Tsai PL, Tsai TH (2002). Simultaneous determination of berberine in rat blood, liver and bile using microdialysis coupled to high-performance liquid chromatography. J. Chromatogr., A 961: 125-130.
19. Wang XL, Wang RF, Xing DM, Su H, Ma C, Ding Y, Du LJ (2005). Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci., 77: 3058-3067.
20. Wang XQ, Yang MW, Liu, FF, Lu FE, Xu LJ, Zuo X (2007). Effect of Rhizoma Coptidis and Radix Rehmanniae with different ratio on pharmacokinetics of berberine in rats. China J. Chin. Mater. Med., 32: 1795-1797.
21. Wei YZ, Yao ZB, Yuan QF, Chen YC (1995). Protective effects of berberine on rat hippocampus against cerebral ischemia. Chin. J. Neuroanat., 11:315-321.
22. Wu JF, Shi YJ, Liu TP (1995). Protective effects of berberine on cerebral ischemia in mice and rats. Chin. J. Pharmacol. Toxicol., 9: 100-103.
23. Wu XX, Peng J, Fan B, Yu YH (2009). Pharmacokinetics of three alkaloids in Huanglianjiedu dcoction in rat serum by LC-MS-MS. China J. Chin. Mater. Med., 39: 1276-1280.
24. Wu Y, Jia JP (2007). Establishment of animal model with cerebral ischemia and its influrencing factors. Chin. J. Cerebrovasc., Dis. 4: 42-46.
25. Xi GM, Yu DZ, Fan HY, Yu SZ, Li CY, Wang LC (2001). Effects of berberine on neuronal apoptosis after global cerebral ischemia in mice. J. Apoplexy Nerv. Dis., 18: 292-293.
26. Xi GM, Yu DZ, Fan HY, Yu SZ, Li CY, Wang LC (2001). Effects of berberine on neuronal apoptosis related gene after global cerebral ischemia in mice. Stroke Nerv., Dis., 8: 323-325.
27. Xi GM, He GH, Huang CF. Effect of berberine on brain infarct (2003). J. Apoplexy Nerv. Dis., 20: 459-460.
28. Xu JH, Matsumoto K, Tohda M, Watanabe H, Zhang SH, Yu QH, Shen J (2000). Protective effect of Oren-gedoku-to (Huang-Lian-Jie-Du-Tang) against impairment of learning and memory induced by transient cerebral ischemia in mice. J. Ethnopharmacol., 73: 405-413.
29. Yu S, Yu YL, Lu SS, Liu L, Liu XD (2008). Pharmacokinetics of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in diabetic rats. J. China Pharm., University 39: 526-529.
30. Zhou XQ, Zeng XN, Kong H, Sun XL (2008). Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci. Lett., 447: 31-36.